AETHLON MEDIC.NEW DL-,001 (EJU.MU)

Munich - Munich Delayed Price. Currency in EUR

0.3529

-0.0019

(-0.54%)

At close: 09:00AM CEST

Advertisement

Loading interactive chart...

Simply Wall St.
Aethlon Medical Third Quarter 2023 Earnings: US$0.12 loss per share (vs US$0.16 loss in 3Q 2022)
Aethlon Medical ( NASDAQ:AEMD ) Third Quarter 2023 Results Key Financial Results Net loss: US$2.85m (loss widened by...
Simply Wall St.
Analysts Expect Aethlon Medical, Inc. (NASDAQ:AEMD) To Breakeven Soon
With the business potentially at an important milestone, we thought we'd take a closer look at Aethlon Medical, Inc.'s...
Zacks Small Cap Research
AEMD: New CRO to Help Advance Studies; Expanded Team to Facilitate Efforts
By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT New CRO to facilitate study of the Hemopurifier® in a range of cancers To advance its medical device, the HemoPurifier®, through clinical studies towards potential regulatory approval and commercialization, Aethlon Medical’s (NASDAQ:AEMD) has launched several recent initiatives. Among other steps, the company has: ▪ Embarked on launching

Advertisement